BUCK KRISTEN K (EVP, R&D and CMO) received a stock award from LISATA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/11/2024ACC: 0001879231-24-000002
Officer· EVP, R&D and CMO
Since Sep 2021
+35.12K
Net shares
Net buyer
$18.1K
Total sold
0
Open market trades
0B · 0S
5
Total transactions
41K acquired · 5.88K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+27K
Price / share
—
Trade value
—
% of position
82.0%
1/9/2024
32.91K→59.91K
Common Stock
Direct
Shares
−3.22K
Price / share
$3.08
Trade value
$9.92K
% of position
5.4%
1/9/2024
59.91K→56.69K
Common Stock
Direct
Shares
−2.15K
Price / share
$3.08
Trade value
$6.61K
% of position
3.8%
1/9/2024
56.69K→54.55K
Common Stock
Direct
Shares
−512.00
Price / share
$3.00
Trade value
$1.54K
% of position
0.9%
1/10/2024
54.55K→54.03K
Total
Net shares
+21.12K
Net value
-$18.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2024 | A · Award | +27K | — | — | 82.0% | 32.91K | 59.91K |
| Common Stock Direct | 1/9/2024 | F · Tax Withholding | −3.22K | $3.08 | $9.92K | 5.4% | 59.91K | 56.69K |
| Common Stock Direct | 1/9/2024 | F · Tax Withholding | −2.15K | $3.08 | $6.61K | 3.8% | 56.69K | 54.55K |
| Common Stock Direct | 1/10/2024 | F · Tax Withholding | −512.00 | $3.00 | $1.54K | 0.9% | 54.55K | 54.03K |
| Total | +21.12K | -$18.07K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14K shares
Shares
+14K
Strike price
3.08
Held after
14K
Exercisable
—
1/9/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock14K shares | 1/9/2024 | A · Award | +14K | 3.08 | — | 14K |